pyrrolidine dithiocarbamate has been researched along with 2,4-thiazolidinedione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, H; Ogawa, D; Ohga, S; Okada, S; Shikata, K; Shikata, Y; Usui, H; Wada, J; Yozai, K | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Macrophage Activation; Male; NF-kappa B; Pioglitazone; PPAR gamma; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thiocarbamates; Transforming Growth Factor beta | 2007 |